CompletedNCT00312494
Ziprasidone with lithium or divalproex for acute mania in bipolarity
About this title
Read the official source — NCT00312494Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Dothan and 65 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateApril 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 680
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00312494
- Official title
Show the full official title
A Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dothan · Scottsdale · Little Rock
51 more locations
- Cerritos
- Costa Mesa
- Escondido
- Glendale
- Huntington Beach
- Los Angeles
- National City
- Oceanside
- San Diego
- Torrance
- Hartford
- New Britain
- DeLand
- Fort Lauderdale
- Gainesville
- Hollywood
- Jacksonville
- Lauderhill
- North Miami
- Atlanta
- Honolulu
- Des Plaines
- Hoffman Estates
- Schaumburg
- Greenwood
- Prairie Village
- Glen Burnie
- Flowood
- Kansas City
- Saint Charles
- St Louis
- Las Vegas
- Clementon
- Princeton
- Amityville
- Buffalo
- Cedarhurst
- Elmsford
- Raleigh
- Cincinnati
- Cleveland
- Oklahoma City
- Philadelphia
- Charleston
- Dallas
- Irving
- Plano
- San Antonio
- Richmond
- Bellevue
- Kirkland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Did this study involve medication?
Yes. The study involved medication, including Placebo and Ziprasidone.
Who was this study for?
Listed age limits: 18 years to 65 years.
